AI-generated summary
This randomized clinical trial compared Nd:YAG laser therapy at 1064 nm with an intramuscular epidermal growth factor (EGF) injection in 29 patients with chronic painful myogenic temporomandibular disorder. The authors report that both groups showed significant pain reduction and quality-of-life improvement, with no significant difference between the two treatments.
- Participants
- 29
- Who or what was studied
- Patients with chronic painful myogenic temporomandibular disorder (TMD) based on diagnostic criteria for temporomandibular disorders
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract reports a small sample of 29 patients split into two groups of 13 and 14, and does not describe a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objective
The aim of this clinical trial was to evaluate the effectiveness of Piano level laser therapy using Nd-YAG laser and intramuscular EGF injection in pain alleviation, function, and quality of life improvement in patients suffering from myogenic TMD.
Materials And Methods
A randomized clinical trial was performed on 29 patients suffering from chronic painful myogenic TMD based on diagnostic criteria for temporomandibular disorders. Group I (n = 13patients) was treated using 1064 nm Nd-YAG Laser (4 sessions once/week). Group II (n = 14 patients) was treated by intramuscular injection of EGF. Pain using numerical rating score, pain free opening and unassisted maximum opening were measured at baseline, 7,14,21 days, 1 and 3 months. Quality of life using OHIP-14 was assessed at baseline, 1 and 3 months.
Results
Results showed that there was a significant pain reduction (P < 0.000) and increase in pain free opening (P < 0.0001) in both test groups. However, only group I showed a significant increase in maximum opening (P = 0.007). Quality of life significantly improved in both groups (P = 0.0001). There was no significant difference between the two treatments in pain scores, pain free opening, maximum opening nor quality of life.
Conclusion
Both treatment modalities offered effective and cost-effective non- to minimally invasive treatment options for myogenic TMD with no side effects. CLINICAL RELEVANCE: Myogenic TMD forms a public health issue and is a common musculoskeletal problem causing pain and disability. The proposal of effective, non-invasive, and affordable treatment options can help solve this issue.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.